News
DelveInsight's CLK Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
Despite challenges in the biopharma sector, Sophia Genetics SA (SOPH) showcases robust growth and strategic advancements in ...
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...
AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...
Potential lumpiness in revenue due to milestone-based contracts was acknowledged by management.
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...
Bennett tested positive for the gene aged 18 but was unable to get the surgery until this year due to the pandemic and hospital delays. She said: "Even though I'd prepared myself for that possibility ...
In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...
Respiratory infections like COVID-19 and the flu can activate dormant cancer cells in breast cancer patients who are in remission, new research finds. The study, published in Nature, found that common ...
From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results